AGP Picks
View all

Science & Technology Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science & Technology Watch.

Press releases published on September 28, 2026

Zayed Sustainability Prize Unveils 2027 Finalists Following Record-Breaking Global Entry
Top Pipette Tip Manufacturer Advances Precision Laboratory Consumable Solutions
Coroner Finds Multiple Psychiatric Drugs in Mother-Daughter Murder-Suicide; Citizens Commission on Human Rights International Calls for  Violence Cases to Undergo Same Tests
IDT Corporation Reports Record Fourth Quarter and Fiscal Year 2026 Results
Waldencast plc Announces First Half 2026 Financial Results
Azurity Pharmaceuticals Receives FDA Approval for Lamlique™ (lamotrigine) oral suspension
Exascale Labs Holdings Inc. Reports 111% Revenue Growth for Full Fiscal Year 2026 and Provides Business Update Following Successful Nasdaq Listing
Natural Alternatives International, Inc. Announces Fiscal 2026 Q4 and YTD Results
MedLegalPsych Launches Independent Psychiatric Assessment and IME Services in Winnipeg for Insurers, Employers, and Disability Case Managers
Instore Products Solutions and Smart Eco Bag Launch Canada’s First Domestically Manufactured Reusable Bags
Instore Products Solutions et Smart Eco Bag lancent les premiers sacs réutilisables scellés par fabriqués au Canada
U.S. Government Selects Navitas to Develop Next-Generation 10 kV SiC Power Semiconductors
Anant Ambani-Led Kutch Renewable Hub Projected to Avoid 29 Million Tonnes of CO2 a Year, Analysis Finds
SI-BONE Receives FDA 510(k) Clearance for iFuse Granite Onyx™, Extending Its Compromised Bone Franchise Beyond the Pelvis
Attovia Therapeutics to Present New Data on ATTO-1310 and ATTO-2306 at EADV 2026 and Fall Clinical Dermatology Conference 2026
Applied Digital Sets Fiscal First Quarter 2027 Conference Call for Wednesday, October 7, 2026, at 5:00 p.m. Eastern Time
AMD to Acquire World Labs to Advance the Future of AI Compute
Teva Continues Biosimilar Momentum with U.S. FDA Approval of DEGEVMA™ (denosumab-adet), a Biosimilar to Xgeva® (denosumab)
AI/R Compass UOL leva ao AWS Marketplace solução de IA que habilita empresas a acelerar a saída de mainframe
WeGuide Secures A$1.9M to Commercialise Digital Biomarkers

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Science & Technology Watch

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.